Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-02-06

Clinical Trial Update: Use-Results Surveillance Study of Harvoni® in Japanese Patients With Chronic Genotype 1 Hepatitis C Virus Infection

View source ↗

Summary

This is a completed use-results surveillance study of Harvoni (ledipasvir/sofosbuvir) in Japanese patients with chronic genotype 1 Hepatitis C. It reports real-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HARVONI (Ledipasvir and Sofosbuvir)

Snippet

Sponsor: Gilead Sciences | Conditions: Hepatitis C | Status: COMPLETED